219 related articles for article (PubMed ID: 17355546)
1. Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.
Láinez MJ; Galván J; Heras J; Vila C
Eur J Neurol; 2007 Mar; 14(3):269-75. PubMed ID: 17355546
[TBL] [Abstract][Full Text] [Related]
2. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.
Christie S; Göbel H; Mateos V; Allen C; Vrijens F; Shivaprakash M;
Eur Neurol; 2003; 49(1):20-9. PubMed ID: 12464714
[TBL] [Abstract][Full Text] [Related]
3. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
4. [Almotriptan vs. ergotamine plus caffeine for acute migraine treatment. A cost-efficacy analysis].
Slof J; Láinez JM; Comas A; Heras J
Neurologia; 2009 Apr; 24(3):147-53. PubMed ID: 19418289
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
Diener HC; Jansen JP; Reches A; Pascual J; Pitei D; Steiner TJ;
Eur Neurol; 2002; 47(2):99-107. PubMed ID: 11844898
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.
Linder SL; Mathew NT; Cady RK; Finlayson G; Ishkanian G; Lewis DW
Headache; 2008 Oct; 48(9):1326-36. PubMed ID: 18484981
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
Le Jeunne C; Gómez JP; Pradalier A; Titus i Albareda F; Joffroy A; Liaño H; Henry P; Lainez JM; Geraud G
Eur Neurol; 1999 Jan; 41(1):37-43. PubMed ID: 9885327
[TBL] [Abstract][Full Text] [Related]
8. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
Goadsby PJ
Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
10. Almotriptan and zolmitriptan in the acute treatment of migraine.
Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC
Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
12. Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan.
Díez FI; Straube A; Zanchin G
J Neurol; 2007 Feb; 254(2):242-9. PubMed ID: 17334957
[TBL] [Abstract][Full Text] [Related]
13. Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.
Dowson AJ; Massiou H; Laínez JM; Cabarrocas X
Cephalalgia; 2002 Jul; 22(6):453-61. PubMed ID: 12133045
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of almotriptan in postmarketing surveillance studies.
Pascual J
Eur Neurol; 2005; 53 Suppl 1():34-40. PubMed ID: 15920336
[TBL] [Abstract][Full Text] [Related]
15. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
[TBL] [Abstract][Full Text] [Related]
16. Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.
Allais G; Bussone G; D'Andrea G; Moschiano F; d'Onofrio F; Valguarnera F; Manzoni GC; Grazzi L; Allais R; Benedetto C; Acuto G
Cephalalgia; 2011 Jan; 31(2):144-51. PubMed ID: 20660540
[TBL] [Abstract][Full Text] [Related]
17. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
18. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
Goadsby PJ; Zanchin G; Geraud G; de Klippel N; Diaz-Insa S; Gobel H; Cunha L; Ivanoff N; Falques M; Fortea J
Cephalalgia; 2008 Apr; 28(4):383-91. PubMed ID: 18294251
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.
Dahlöf CG; Pascual J; Dodick DW; Dowson AJ
Cephalalgia; 2006 Apr; 26(4):400-8. PubMed ID: 16556240
[TBL] [Abstract][Full Text] [Related]
20. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
